Kestra Private Wealth Services, LLC Dexcom Inc Transaction History

Kestra Private Wealth Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$59.83 - $87.57 $638,445 - $934,459	-10,671 Reduced 81.55%	2,415 $210,000
Q1 2025 May 05, 2025	BUY	$67.74 - $90.75 $138,121 - $185,039	2,039 Added 18.46%	13,086 $893,000
Q4 2024 Jan 28, 2025	BUY	$65.68 - $81.01 $234,740 - $289,529	3,574 Added 47.83%	11,047 $859,000
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $478,272 - $867,316	7,473 New	7,473 $500,000
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $49,632 - $97,009	-730 Closed	0 $0

Q1 2022 May 26, 2022	SELL	$94.08 - $130.2 $5,832 - $8,072	-62 Reduced 7.83%	730 $93,000
Q4 2021 Jan 21, 2022	SELL	$129.87 - $162.82 $11,818 - $14,816	-91 Reduced 10.31%	792 $106,000
Q3 2021 Oct 21, 2021	BUY	$106.71 - $143.18 $6,829 - $9,163	64 Added 7.81%	883 $120,000
Q2 2021 Jul 30, 2021	SELL	$80.99 - $107.93 $367,046 - $489,138	-4,532 Reduced 84.69%	819 $87,000
Q1 2021 May 11, 2021	SELL	$84.79 - $104.74 $30,693 - $37,915	-362 Reduced 6.34%	5,351 $480,000
Q4 2020 Jan 21, 2021	BUY	$78.0 - $104.5 $445,614 - $597,008	5,713 New	5,713 $2.07 Billion

1,086

376M

6.76M

7.24M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Kestra Private Wealth Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Private Wealth Services, LLC with notifications on news.